Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The new assay can help develop products for hair re-growth.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

Dexmedetomidine-loaded microneedles effectively reduce pain without sedation.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

New compounds may help treat prostate issues without affecting androgen receptors.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

TRPV3 and TRPV6 channels change structure to regulate calcium and heat responses.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Dutasteride and finasteride affect different cell types differently.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Vitamin D receptor interacts with certain dietary components to help prevent diseases and regulate hair growth.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Carvacrol activates the TRPV3 channel, which may help design new skin treatments.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.